PMC:7696151 / 32449-32734
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 910 | 214-222 | Species | denotes | patients | Tax:9606 |
| 963 | 149-152 | Chemical | denotes | HCQ | MESH:D006886 |
| 995 | 75-99 | Disease | denotes | QT-interval prolongation | MESH:D008133 |
| 996 | 223-231 | Disease | denotes | infected | MESH:D007239 |
| 997 | 237-245 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T219 | 44-246 | Sentence | denotes | ECG modification, resulting in QT-interval prolongation, is a characteristic side effect associated with HCQ treatment that has been shown in several clinical studies on patients infected with COVID-19. |